Ind-Swift Laboratories Ltd.

•

indswiftlabs.comBSE: 532305NSE: INDSWFTLAB

Market Cap₹ 3,358 Cr.

Current Price

High / Low₹ 404 / 87

Stock P/E58.6

Book Value₹ 172

Price to Book0.53

Dividend Yield0.00 %

ROCE24.2 %

ROE24.7 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a good return on equity (ROE) track record: 3 Years ROE 31.4%
Company has a healthy return on capital (ROCE) of 30.9%
Latest quarter profit grew 181.3% YoY, showing strong momentum
Company comfortably covers its interest (89.3x coverage)
Institutional investors have been accumulating - FII+DII up 5.7pp

CONS

Company is loss-making at the operating / net level
Operating cash flow has been negative in recent years
Recent results are weak - TTM profit is down 87.6% versus prior year
Receivables are growing faster than sales - a possible quality concern
A large part of profit comes from other income (31.6% of PBT)
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.01x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	INDSWFTLAB	386.10	58.57	3357.59	0.00	24.68	181.33	191.45	25.35	24.24	17.52

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	310	290	288	529	147	148	129	142	153	153	151	170	191
	250	224	236	437	154	145	135	147	149	151	147	149	166
Operating Profit	60	66	52	91	-6	3	-7	-4	4	1	4	21	25
OPM %	19.43%	22.67%	17.98%	17.26%	-4.41%	1.98%	-5.16%	-3.10%	2.36%	0.96%	2.76%	12.11%	13.13%
	6	7	7	458	51	17	16	216	15	18	22	-3	8
Interest	20	21	21	3	10	10	10	-27	1	2	1	-2	1
Depreciation	14	13	14	20	6	6	6	7	7	7	9	8	8
Profit before Tax	32	39	24	527	29	5	-7	230	10	10	16	12	33
Tax %	45.01%	17.87%	19.31%	6.29%	-0.10%	3.83%	16.41%	3.55%	16.52%	22.24%	41.92%	-26.34%	24.46%
Net Profit	0	0	0	0	9	4	0	222	9	8	10	15	25
	2.92	5.36	3.29	83.55	4.34	0.67	-0.82	33.04	1.28	1.00	1.17	1.81	2.84

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	653	697	763	757	780	891	1,039	1,207	1,281	562	665
	546	591	628	630	636	709	843	978	1,027	581	613
Operating Profit	107	106	134	126	143	183	196	229	254	-19	51
OPM %	16.42%	15.19%	17.59%	16.67%	18.40%	20.51%	18.83%	18.98%	19.85%	-3.45%	7.73%
	1	17	24	120	33	23	43	7	432	305	45
Interest	106	90	35	92	107	100	96	92	51	3	1
Depreciation	85	88	87	104	90	87	131	57	53	24	32
Profit before Tax	-83	-55	36	50	-20	18	13	87	582	258	71
Tax %	29.10%	29.24%	38.93%	41.73%	-7.17%	117.48%	117.15%	44.72%	27.56%	2.82%	19.63%
Net Profit	-59	-39	22	29	-21	-3	-2	48	421	251	57
EPS	0.00	0.00	0.00	0.00	0.00	-4.28	-4.28	-4.28	71.24	36.44	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: -2%
5 Years:: -6%
3 Years:: -19%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: 26%
5 Years:: 40%
3 Years:: 64%
1 Year:: 256%

RETURN ON EQUITY

10 Years:: 7%
5 Years:: 19%
3 Years:: 31%
Last Year:: 25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	41	45	45	48	59	59	59	59	59	69
	476	483	506	540	581	544	541	622	872	1,030
	1,250	998	832	1,058	1,006	978	912	802	14	39
Trade Payables	132	102	129	127	135	139	176	204	94	110
	286	403	416	73	10	38	60	107	94	146
Total Liabilities	2,185	2,031	1,927	1,845	1,792	1,758	1,749	1,794	1,133	1,394
	1,099	1,033	925	901	843	739	628	585	5	260
Capital Work in Progress	78	61	62	13	4	11	9	8	0	0
	18	31	31	31	17	36	29	30	111	213
	356	344	317	317	343	376	429	439	10	114
	0	0	0	0	0	0	0	0	169	165
Cash & Bank	23	16	9	30	11	12	21	18	432	428
	612	546	583	554	574	586	633	714	406	213
Total Assets	2,185	2,031	1,927	1,845	1,792	1,758	1,749	1,794	1,133	1,394

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	79	96	73	-65	125	135	150	194	-163	-25
Cash from Investing	-30	-31	-17	-12	-9	-10	5	-13	-104	-110
Cash from Financing	-48	-69	-62	100	-133	-124	-141	-186	681	69
	2	-4	-6	23	-17	1	14	-4	413	-66

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	42.01	42.00	42.00	40.94	40.94	39.50	39.50	42.99	42.93
	1.27	0.65	0.46	3.07	4.27	14.80	14.33	13.88	10.70
	0.94	0.94	0.94	0.91	0.91	0.68	0.68	0.00	0.17
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	55.80	56.41	56.60	55.07	53.87	45.02	45.50	43.12	46.20

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-06

Copy of Newspaper Publication

2026-09-06 - Ind-Swift Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-05

Shareholders meeting

2026-09-05 - Ind-Swift Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026.

2026-09-04

Copy of Newspaper Publication

2026-09-04 - Ind-Swift Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-04

General Updates

2026-09-04 - Outcome of Preferential Issue Committee meeting held on Friday, 4th September, 2026, as per Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

2026-09-02

Outcome of Board Meeting

2026-09-02 - Ind-Swift Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.

2026-08-28

Spurt in Volume

2026-08-28 - Significant increase in volume has been observed in Ind-Swift Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ind-Swift Laboratories Limited has submitted their response.

2026-08-27

General Updates

2026-08-27 - Ind-Swift Laboratories Limited has informed the Exchange about Company's Clarification on Spurt in Volume

2026-08-26

Spurt in Volume

2026-08-26 - Significant increase in volume has been observed in Ind-Swift Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

2026-08-20

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-20 - Ind-Swift Laboratories Limited has informed the Exchange about Transcript of Earning Call held on August 17, 2026

News

Recent coverage and analyst commentary for INDSWFTLAB

Loading news…

🤖

AI Stock Analyst

Ind-Swift Laboratories Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

INDSWFTLAB

386.10

58.57

3357.59

0.00

24.68

181.33

191.45

25.35

24.24

17.52

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

310

290

288

529

147

148

129

142

153

151

170

191

250

224

236

437

154

145

135

147

149

151

147

149

166

Operating Profit

-6

-7

-4

OPM %

19.43%

22.67%

17.98%

17.26%

-4.41%

1.98%

-5.16%

-3.10%

2.36%

0.96%

2.76%

12.11%

13.13%

458

216

-3

Interest

-27

-2

Depreciation

Profit before Tax

527

-7

230

Tax %

45.01%

17.87%

19.31%

6.29%

-0.10%

3.83%

16.41%

3.55%

16.52%

22.24%

41.92%

-26.34%

24.46%

Net Profit

222

2.92

5.36

3.29

83.55

4.34

0.67

-0.82

33.04

1.28

1.00

1.17

1.81

2.84

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

653

697

763

757

780

891

1,039

1,207

1,281

562

665

546

591

628

630

636

709

843

978

1,027

581

613

Operating Profit

107

106

134

126

143

183

196

229

254

-19

OPM %

16.42%

15.19%

17.59%

16.67%

18.40%

20.51%

18.83%

18.98%

19.85%

-3.45%

7.73%

120

432

305

Interest

106

107

100

Depreciation

104

131

Profit before Tax

-83

-55

-20

582

258

Tax %

29.10%

29.24%

38.93%

41.73%

-7.17%

117.48%

117.15%

44.72%

27.56%

2.82%

19.63%

Net Profit

-59

-39

-21

-3

-2

421

251

EPS

0.00

-4.28

71.24

36.44

—

Dividend Payout %

0.00%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

476

483

506

540

581

544

541

622

872

1,030

1,250

998

832

1,058

1,006

978

912

802

Trade Payables

132

102

129

127

135

139

176

204

110

286

403

416

107

146

Total Liabilities

2,185

2,031

1,927

1,845

1,792

1,758

1,749

1,794

1,133

1,394

1,099

1,033

925

901

843

739

628

585

260

Capital Work in Progress

111

213

356

344

317

343

376

429

439

114

169

165

Cash & Bank

432

428

612

546

583

554

574

586

633

714

406

213

Total Assets

2,185

2,031

1,927

1,845

1,792

1,758

1,749

1,794

1,133

1,394

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-65

125

135

150

194

-163

-25

Cash from Investing

-30

-31

-17

-12

-9

-10

-13

-104

-110

Cash from Financing

-48

-69

-62

100

-133

-124

-141

-186

681

-4

-6

-17

-4

413

-66

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

42.01

42.00

40.94

39.50

42.99

42.93

1.27

0.65

0.46

3.07

4.27

14.80

14.33

13.88

10.70

0.94

0.91

0.68

0.00

0.17

Government

0.00

55.80

56.41

56.60

55.07

53.87

45.02

45.50

43.12

46.20

Ind-Swift Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Ind-Swift Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI